Member Info for jona35

So scarletvixen been hounding there bb thats another one of hers to rise over 80% i can feel a paten here

What was it scarletvixen said oh dear oh dear

SV will go quite when they buy in then after they sell it starts all over again .I can also research posters timing share price at the time ect ect SV been exposed .

And how do you know this SV.. just look at your posts trolling lse how pathetic and sad no time for people like you

Im here for one reason only and that ios big match days. Its a 5 mill cap with two ex GSK guys owning 10% and BIO aim wizard who normally m bags plus at 5% saying 5 deals all worth 4p each in works plus options if they hit is 4p plus for 3 months just for first tier. #APTA

Hemo never sure whats coming next waiting for rns no twitter and no communication ..APTA tweeter updates always reply RNS. vlad needs a PR i would not mind someone employed to do that job ..its not the company but the pr to share holders we need here god its like watching paint dry at times ..not my bigest holding but come on lets have some information vlad i just dont think he understands how AIM works at times anyway lets hope we get good news soon

Now would be the time to buy then imo recovery's do and can happen very fast the bod think so with the first options at 4p for three months going up to 50x the placement price all to play for here imo but its not for everyone some will come wanting a lower buy in price and will as we have see on other bb they do but mostly with post of no research what so ever this has to be a buy and hold for me but each to there own ..sorry if i cant post after this got a flight to catch so leave you guys to it

The fact they managed to raise money at all was good enought The Issue Price represents a discount of 78.95 per cent. to the closing price per Ordinary Share of 4.75 pence at close of business on 28 July 2023 when most company's cant which fully funds them for at least 18 months and some but not all on the 17th august were bought in the open market .on the same day they had an RNS on the contract win there threshold was reached

Hi guys what the latest here been very busy of late is the drill back up and ect as still have a small holding here please dont bite my head off some bloke just did on ecr for asking a question guess he does'not like the lady lol ..still down on my investment here

You seem very bitter and twisted .do you normally speak to females like that for asking a simple question .do you normally speak to your wife or maybe girlfriend like that .that's if anyone would have you i guess ..You remind me of a guy i was once with but lets not go there ..all the best anyway guess i shouldn't of asked simple questions

Oh right so you wouldn't give this company the time of day then...It just seems to me that a new structure that with new bod. so you don't think anything will change here ..or would you invest here at some point if the share price fell

Can i ask why you hate this company so much after it would seem there are new people involved and things look like there about to turn things around here ...Have you lost a lot of money in this company. I would like to here both sides of the argument thanks

The other i see in all these shows is buying of shares in a company they like ..now who wouldn't buy in.. for all we know there could be more TR1 i would expect that but the two ex GSK plc employees buying 5% each does make you wonder what the connection is.. I cant see that just being a gamble and with Nicholas slater wiizzkid holder of companys that have multi bagged you can find him on twitter and see that for your self so i think its a safe bet here ..But as with all company's do come risks but also very high rewards so we wait for updates and news from RNS and there own website and i am sure we will get to know soon

Https://twitter.com/AptamerGroup

Aptamer Group

@AptamerGroup

·

24m

1 week until Bio-Europe! Need a boost for your antibody assays and drug targeting? Meet the team at Bio-Europe or arrange a meeting via the partnering app next week to explore #Optimer tech. #BioEurope #ScienceUnlimited

There have been all over doing these this year these events create contracts

Some good volume imho everyone should have some of these i have done all the research as per my posts so now we wait for news update i dont think its to far off now

Regardless of any good or bad RNS nobody wants to hear the sad news of the death of an employee our thoughts as share holders even ones not should be mindful of that .your thoughts should be with there family's

Looks very promising here now .continue to hold .so there is gold in the area always a good sign .you normaly find these systems find there way to the bigger ones ..i bit like tree roots

Thamk you el;rico sorry guys should of posted the link

Dr Leach holds BA and DPhil degrees in Chemistry from Oxford University. He joined EMBL-EBI in August 2016 from GSK Research and Development, where he enjoyed a successful career since 1994, most recently as Global Head of Biomolecular Sciences. He also served as a Trustee of the Cambridge Crystallographic Data Centre from 2006-2015 and was editor of the Journal of Computer-Aided Molecular Design from 1997-2012. so a simple one really is why would dr andrew leach be so keen to hold just over 5% remember these guys are in the business ..imho unless you knew something was happening why would you buy 5% in this microcap company or he has seen something he really likes and with his conections will not be long before more stock is taken up

The new options will have an exercise price of 1p, which is equal to the price at which the Company's fundraise was completed in July/August of this year.

The new options will be subject to stretching performance targets as follows:

(i) 16 per cent, on announcement of FY24 audited results in line with expectations and the share price having remained at or above 4 times the issue price for at least 3 months;

(ii) 24 per cent, on announcement of FY25 audited results in line with expectations and the share price having remained at or above 7 times the issue price for at least 3 months;

(iii) 40 per cent, on announcement of FY26 audited results in line with expectations and the share price having remained at or above 10 times the issue price for at least 3 months;

(iv) 10 per cent, on announcement of FY26 audited results in line with expectations and the share price having remained at or above 30 times the issue price for at least 3 months; and

(v) 10 per cent, on announcement of FY26 audited results in line with expectations and the share price having remained at or above 50 times the issue price for at least 3 months.

All in the money share options would vest in the event that the Company is acquired (or in the event of a transaction with a similar effect). from one of the latest RNS so i asked myself this why would a company be expecting to basically have a share price over 50p lets say to keep it simple but the best bit of the puzzle is at the end .....Takeover on the cards??? All in the money share options would vest in the event that the Company is acquired (or in the event of a transaction with a similar effect... is it all starting to add up yet ? then we come to who is buying stock its all there in the RNS said it before i will say it again something big is going on behind closed doors imo of course ..its all out there to research and so are the clues ..take care guys